Elevance Health, Inc. (ELV) Covered Calls

Elevance Health, Inc. is a leading health insurance provider and health services innovator. Operating primarily as a Blue Cross Blue Shield licensee in 14 states, it serves millions of members through its Health Benefits and Carelon segments. Carelon provides pharmacy, behavioral, and clinical services, driving the firm’s transition toward a vertically integrated care provider. The company leverages advanced data analytics and AI to enhance whole-health outcomes and manage medical costs.

You can sell covered calls on Elevance Health, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for ELV (prices last updated Fri 4:16 PM ET):

Elevance Health, Inc. (ELV) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
338.98 +6.73 336.25 340.00 2.0M 14 74
Covered Calls For Elevance Health, Inc. (ELV)
Expiration Strike Call Bid Net Debit Return
If Flat		 Annualized
Return If Flat
Feb 20 340 7.20 332.80 2.2% 53.5%
Mar 20 340 12.60 327.40 4.4% 37.3%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Elevance Health, Inc. (ELV), formerly Anthem, is a diversified health giant that has evolved from a traditional insurer into a comprehensive health services partner. By combining its massive Blue Cross Blue Shield insurance footprint with its rapidly growing Carelon services arm, the company executes a "whole-health" strategy that integrates physical, behavioral, and social health drivers to improve outcomes and lower the total cost of care.

Core Business and Products

  1. Health Benefits: This is the core insurance engine, operating under brands like Anthem Blue Cross and Wellpoint. It provides medical coverage to over 45 million members across commercial, Medicare, and Medicaid markets. In 2026, the company is managing a "reset year" for Medicaid, focused on repricing and portfolio discipline to counter margin pressures from sicker member populations.
  2. Carelon Services: A high-growth segment that "insources" complex clinical functions. It includes Carelon Behavioral Health and Carelon Home (following the 2025 integration of CareBridge), providing specialized care for high-risk patients. By capturing the service margin on top of the insurance premium, Elevance achieves superior vertical integration.
  3. CarelonRx: The company’s pharmacy benefit manager (PBM), which manages drug spend for millions of lives. It focuses on transparency and specialty pharmacy integration, utilizing data-driven insights to optimize drug therapies and reduce medical waste.

Competitive Landscape

The managed care space is a battle of scale and vertical integration. Elevance’s most formidable rival is UnitedHealth Group, whose Optum wing competes directly with Carelon. In the Medicare and Medicaid sectors, it faces intense competition from Humana, Centene, and Molina Healthcare. For diversified healthcare and pharmacy services, it contends with CVS Health and The Cigna Group. Additionally, its digital health and AI platforms compete with technology-focused entrants such as Google and Block in the realm of predictive health analytics and consumer-facing financial health tools.

Strategic Outlook and Innovation

In 2026, Elevance is navigating a "trough year" with a focus on operational rigor. Management has issued a prudent adjusted EPS guidance of at least $25.50, preparing for a return to 12% growth in 2027. A major 2026 milestone is the expansion of its "AI-powered Virtual Assistant" to its entire Medicare membership, providing personalized cost estimates and care navigation. Innovation is also centered on "Value-Based Care" for home-bound seniors, utilizing Carelon’s data platforms to reduce hospital readmissions by 20%. Strategically, the company is exiting low-margin Medicare Part D markets to prioritize margin stability over membership growth. By leveraging its "Sydney Health" app and an "Edge AI" partnership, Elevance is automating clinical prior authorizations, aiming to shave significant basis points off its administrative expense ratio. The goal is to solidify a digital-first operating model that makes healthcare simpler and more affordable for the 1 in 3 Americans it serves through its Blue-branded affiliations.